Dabrafenib in BRAFV600E mutant pilocytic astrocytoma

被引:0
|
作者
Sora Yasri
Viroj Wiwanitkit
机构
[1] KMT Primary Care Center,
[2] DY Patil University,undefined
来源
Child's Nervous System | 2020年 / 36卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:893 / 893
相关论文
共 50 条
  • [41] BRAFV600E Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics
    Soria, Xavier
    Vilardell, Felip
    Maiques, Oscar
    Barcelo, Carla
    Siso, Pol
    de la Rosa, Ines
    Velasco, Ana
    Cuevas, Dolors
    Santacana, Maria
    Gatius, Sonia
    Matias-Guiu, Xavier
    Rodrigo, Alberto
    Macia, Anna
    Marti, Rosa M. M.
    [J]. CANCERS, 2021, 13 (20)
  • [42] ANALYSIS OF CELLULAR AND MOLECULAR CHANGES ACCOMPANYING BRafV600E - TARGETED TREATMENT IN A MODEL OF PEDIATRIC ASTROCYTOMA
    Lerner, Robin
    Harness, Julie
    Yoshida, Yasuyuki
    Santos, Raquel
    De La Torre, Jacqueline
    Nicolaides, Theo
    Ozawa, Tomoko
    James, David
    Petritsch, Claudia
    [J]. NEURO-ONCOLOGY, 2013, 15 : 14 - 15
  • [43] Dabrafenib and Trametinibprolong coagulation through the inhibition of tissue factor in BRAFv600e mutated melanoma cells in vitro
    Scatena, Cristian
    Franceschi, Sara
    Franzini, Maria
    Sanguinetti, Chiara
    Romiti, Nadia
    Caponi, Laura
    Mandala, Mario
    Mazzanti, Chiara Maria
    Naccarato, Antonio Giuseppe
    [J]. CANCER CELL INTERNATIONAL, 2019, 19 (01)
  • [44] Efficacy of vemurafenib, a selective BRAFV600E inhibitor, in combination with a MEK inhibitor in BRAFV600E colorectal cancer models.
    Higgins, Brian
    Kolinsky, Kenneth Daniel
    Yang, Hong
    Kim, Min Jung
    Li, Jia Kui
    Go, Zenaida
    Packman, Kathryn
    Bollag, Gideon
    Su, Fei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [45] A Combinatorial Strategy for Targeting BRAFV600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib)
    Ghosh, Chandrayee
    Kumar, Suresh
    Kushchayeva, Yevgeniya
    Gaskins, Kelli
    Boufraqech, Myriem
    Wei, Darmood
    Gara, Sudheer Kumar
    Zhang, Lisa
    Zhang, Ya-qin
    Shen, Min
    Mukherjee, Sanjit
    Kebebew, Electron
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (08) : 2022 - 2036
  • [46] Diffuse melanosis cutis in the setting of BRAFV600E mutant melanoma and treatment with targeted therapies
    Minocha, Rashi
    Kefford, Richard
    Uribe, Pablo
    Sebaratnam, Deshan F.
    Fernandez-Penas, Pablo
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 (02) : 128 - 130
  • [47] Identification of a Novel Family of BRAFV600E Inhibitors
    Qjn, Jie
    Xie, Peng
    Ventocilla, Christian
    Zhou, Guoqiang
    Vultur, Adina
    Chen, Quan
    Liu, Qin
    Herlyn, Meenhard
    Winkler, Jeffrey
    Marmorstein, Ronen
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 5220 - 5230
  • [48] Intrapatient Homogeneity of BRAFV600E Expression in Melanoma
    Menzies, Alexander M.
    Lum, Trina
    Wilmott, James S.
    Hyman, Jessica
    Kefford, Richard F.
    Thompson, John F.
    O'Toole, Sandra
    Long, Georgina V.
    Scolyer, Richard A.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (03) : 377 - 382
  • [49] Absence of BRAFV600E mutation in odontogenic keratocysts
    Franca, Josiane Alves
    de Sousa, Silvia Ferreira
    Diniz, Marina Goncalves
    Fontes Pereira, Thais dos Santos
    Campos de Resende, Taynara Asevedo
    dos Santos, Jean Nunes
    Gomez, Ricardo Santiago
    Gomes, Carolina Cavalieri
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2018, 47 (02) : 186 - 191
  • [50] Modulation of MHC expression by BRAFV600E in melanoma
    Pollack, B. P.
    Sapkota, B.
    Hill, C. E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S224 - S224